Zentalis Pharmaceuticals, Inc. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -46.38M-118.55M-164.26M-220.83M-276.29M-165.87M
Share-based Compensation 0.62M23.15M35.74M46.84M54.82M67.27M
Deferred Taxes -0.02M-0.05M-0.77M-0.85M
Gains from Investment Securities 1.41M0.30M44.61M-0.06M0.60M0.01M
Asset Writedowns and Impairment 8.80M5.00M
Cash from Operations -39.14M-86.83M-154.09M-163.75M-207.82M-170.86M
Depreciation, Depletion & Amortization
Amortization of Goodwill 3.74M
Amortizatization of Intangibles -0.56M-0.91M3.73M13.16M8.00M
Depreciation & Amortization (CF) 0.11M0.16M0.54M1.43M1.40M1.30M
Change in Working Capital
Change in Receivables -0.78M0.28M-0.41M5.00M
Change in Accured Expenses 7.12M14.31M13.96M15.53M10.92M-18.02M
Investing Activities
Capital Expenditures 0.35M0.76M6.11M2.55M0.58M0.22M
Sales of Property, Plant and Equipment 0.07M
Change in Acquisitions & Divestments 116.91M365.82M421.53M505.31M271.20M
Cash from Investing Activities -0.35M-284.83M-18.11M-114.18M-44.46M176.56M
Financing Activities
Other financing activities 0.05M18.42M
Change in Capital Stock
Shares Issued 172.48M171.97M257.92M235.68M0.35M
Preferred Shares Issued 81.88M14.23M
Misc.
Cash from Financing Activities 81.83M360.44M178.52M261.04M237.30M0.11M
Change in Cash 42.34M-11.22M6.31M-16.89M-14.98M5.81M
Beginning Cash Balance -42.34M11.22M-6.31M59.96M43.02M28.09M
Free Cash Flow -39.49M-87.58M-160.20M-166.30M-208.41M-171.08M
Net Cash Flow 42.34M-11.22M6.31M-16.89M-14.98M5.81M